Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.
Dimitriou F, Orloff MM, Koch Hein EC, Cheng PF, Hughes IF, Simeone E, Montazeri K, Grover P, Mehmi I, Gerard CL, Gaudy-Marqueste C, Grob JJ, Michielin O, Hamid O, Long GV, Sullivan R, Kapiteijn E, Johnson DB, Ascierto PA, Joshua AM, Carvajal RD, Butler MO, Hassel JC, Dummer R. Dimitriou F, et al. Among authors: simeone e. Eur J Cancer. 2024 Nov 30;214:115161. doi: 10.1016/j.ejca.2024.115161. Online ahead of print. Eur J Cancer. 2024. PMID: 39647344 Free article.
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.
Mallardo D, Fordellone M, Ottaviano M, Marano G, Vitale MG, Mallardo M, Capasso M, De Cristofaro T, Capone M, Meinardi T, Paone M, Sabatelli P, De Filippi R, Cesano A, Cavalcanti E, Caracò C, Warren S, Budillon A, Simeone E, Ascierto PA. Mallardo D, et al. Among authors: simeone e. Int J Mol Sci. 2024 Nov 19;25(22):12439. doi: 10.3390/ijms252212439. Int J Mol Sci. 2024. PMID: 39596506 Free PMC article.
The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia.
Tosoni L, Morelli GL, Tomadini G, Lazzarotto D, Filì C, Simeone E, Zannier ME, Callegari C, Fanin M, Battaglia G, Bergnach M, Damiani D, Fanin R, Tiribelli M. Tosoni L, et al. Among authors: simeone e. Blood Cancer J. 2024 Oct 1;14(1):169. doi: 10.1038/s41408-024-01151-2. Blood Cancer J. 2024. PMID: 39353890 Free PMC article. No abstract available.
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
Mallardo D, Sparano F, Vitale MG, Trojaniello C, Fordellone M, Cioli E, Esposito A, Festino L, Mallardo M, Vanella V, Facchini BA, De Filippi R, Meinardi P, Ottaviano M, Caracò C, Simeone E, Ascierto PA. Mallardo D, et al. Among authors: simeone e. Cancer Immunol Immunother. 2024 Jun 8;73(8):160. doi: 10.1007/s00262-024-03728-z. Cancer Immunol Immunother. 2024. PMID: 38850335 Free PMC article.
160 results